News | July 31, 2024
Barentz acquires Anshul Life Sciences to strengthen India portfolio
The acquisition will further strengthen Barentz’ position in India creating a leading life science distribution platform
The acquisition will further strengthen Barentz’ position in India creating a leading life science distribution platform
These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development
Report highlights significant improvements in adolescent well-being in India
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
The inspections concluded with no Form 483 observations or significant critical findings
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
Multidisciplinary central team deployed to assist Gujarat with epidemiological, environmental, and laboratory investigations of AES cases
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
Subscribe To Our Newsletter & Stay Updated
